Yuchi Chen

Dr. Yuchi Chen


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
BWBixu Wang
Bixu Wang
YLYue Lin
Yue Lin
MZMingyuan Zhou
Mingyuan Zhou
SFSiyu Fu
Siyu Fu
BZbingqi zhu
bingqi zhu
FZFangmei Zhou
Fangmei Zhou
Tetrastigma Hemsleyanum Diels et Gilg (Sanyeqing, SYQ), a traditional herb native to China, has been widely used in the treatment of inflammatory diseases, febrile convulsions and dysentery. Previous studies have demonstrated the hypoglycemic, anti-inflammatory and anti-pyretic effects of polysaccharides from SYQ (SYQP). However, the role of SYQP in acute lung injury (ALI) remained unknown. Our present study aimed to explore the protective effects of SYQP in ALI and explained its underlying mechanism. In vivo, Balb/c mice were intragastrically administered with SYQP and dexamethasone (DXMS) for 14 days which were intratracheally instilled (IT) with LPS at the last day. In vitro, A549 cells were pretreated with SYQP, DXMS or TAK-242, following by LPS stimulation for 24 h. The histopathological results showed that SYQP remarkably alleviated pulmonary macrophage infiltration and myeloperoxidase (MPO) levels. Additionally, SYQP evidently suppressed wet/dry (W/D) ratio of lung and white blood cells (WBC) in bronchoalveolar lavage fluid (BALF). Moreover, SYQP markedly reduced TNF-α, IL-6, IL-1β and COX-2 levels both in vivo and in vitro. Meanwhile, SYQP significantly attenuated oxidative stress through upregulating the levels of SOD and GSH-Px and downregulating the expressions of MDA and LDH in vivo, which was confirmed by in vitro results that SYQP could increase SOD activity and decrease MDA and NO contents. Importantly, a decline in protein expressions of TLR4, COX-2, NF-κB p50, phospho-NF-κB p65 and phospho-IκB-α was detected in vivo and in vitro. Taken together, our results demonstrated that SYQP ameliorated LPS-induced ALI by alleviating inflammation and oxidative stress via attenuating TLR4/COX-2/NF-κB signaling pathway.

12 June 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
XBXiaodan Bao
Xiaodan Bao
YTYouying Tang
Youying Tang
YLYishan Lv
Yishan Lv
SFSiyu Fu
Siyu Fu
LYLiu Yang
Liu Yang
FZFangmei Zhou
Fangmei Zhou

25 February 2024 in Chinese Medicine
Verified
Journal Article
Open access
PDF file
YYYangtian Yan
Yangtian Yan
NYNingning Yuan
Ningning Yuan
YCYuchi Chen
Yuchi Chen
YMYun Ma
Yun Ma
ACAli Chen
Ali Chen
WXWei Xiao
Wei Xiao
Background: Diabetic kidney disease (DKD) represents a microvascular complication of diabetes mellitus. Shenkang Pills (SKP), a traditional Chinese medicine formula, has been widely used in the treatment of DKD and has obvious antioxidant effect. Ferroptosis, a novel mode of cell death due to iron overload, has been shown to be associated with DKD. Nevertheless, the precise effects and underlying mechanisms of SKP on ferroptosis in diabetic kidney disease remain unclear. Methods: The active components of SKP were retrieved from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database. Protein–protein interaction (PPI) network and Herb-ingredient-targets gene network were constructed using Cytoscape. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted utilizing the Metascape system database. Additionally, an in vivo model of DKD induced by Streptozotocin (STZ) was established to further investigate and validate the possible mechanisms underlying the effectiveness of SKP. Results: We retrieved 56 compounds and identified 223 targets of SKP through the TCMSP database. Key targets were ascertained using PPI network analysis. By constructing a Herb-Ingredient-Targets gene network, we isolated the primary active components in SKP that potentially counteract ferroptosis in diabetic kidney disease. KEGG pathway enrichment analysis suggested that SKP has the potential to alleviate ferroptosis through HIF signaling pathway, thereby mitigating renal injury in DKD. In animal experiments, fasting blood glucose, 24 h urine protein, urea nitrogen and serum creatine were measured. The results showed that SKP could improve DKD. Results from animal experiments were also confirmed the efficacy of SKP in alleviating renal fibrosis, oxidative stress and ferroptosis in DKD mice. These effects were accompanied by the significant reductions in renal tissue expression of HIF-1α and HO-1 proteins. The mRNA and immunohistochemistry results were the same as above. Conclusions: SKP potentially mitigating renal injury in DKD by subduing ferroptosis through the intricacies of the HIF-1α/HO-1 signaling pathway.

22 March 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YTYouying Tang
Youying Tang
MZMingyuan Zhou
Mingyuan Zhou
ZMZian Mao
Zian Mao
BZBingqi Zhu
Bingqi Zhu
FZFangmei Zhou
Fangmei Zhou
ZDZhishan Ding
Zhishan Ding

7 February 2025 in Molecular Immunology
Verified
Journal Article
Closed access
MZMengjia Zhao
Mengjia Zhao
SCSenmiao Chen
Senmiao Chen
JXJingwen Xu
Jingwen Xu
FZFangmei Zhou
Fangmei Zhou
MZMingyuan Zhou
Mingyuan Zhou
YCYuchi Chen
Yuchi Chen

8 June 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
JXJingwen Xu
Jingwen Xu
YTYouying Tang
Youying Tang
CSChenjun Shen
Chenjun Shen
KLKewei Li
Kewei Li
MZMengjia Zhao
Mengjia Zhao
YCYuchi Chen
Yuchi Chen